Millennium Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $156M | Buy |
2,834,355
+2,159,083
| +320% | +$119M | 0.08% | 134 |
|
2025
Q1 | $47.7M | Buy |
675,272
+267,116
| +65% | +$18.9M | 0.03% | 541 |
|
2024
Q4 | $26.8M | Sell |
408,156
-234,524
| -36% | -$15.4M | 0.01% | 915 |
|
2024
Q3 | $45.2M | Sell |
642,680
-476,044
| -43% | -$33.5M | 0.02% | 623 |
|
2024
Q2 | $92.1M | Sell |
1,118,724
-1,158,455
| -51% | -$95.4M | 0.04% | 312 |
|
2024
Q1 | $199M | Buy |
2,277,179
+1,108,824
| +95% | +$96.8M | 0.09% | 106 |
|
2023
Q4 | $113M | Buy |
1,168,355
+904,404
| +343% | +$87.2M | 0.05% | 199 |
|
2023
Q3 | $23.4M | Sell |
263,951
-66,456
| -20% | -$5.88M | 0.01% | 872 |
|
2023
Q2 | $28.6M | Buy |
330,407
+792
| +0.2% | +$68.7K | 0.01% | 787 |
|
2023
Q1 | $32.1M | Sell |
329,615
-455,835
| -58% | -$44.3M | 0.02% | 691 |
|
2022
Q4 | $81.3M | Sell |
785,450
-1,088,822
| -58% | -$113M | 0.05% | 291 |
|
2022
Q3 | $159M | Buy |
1,874,272
+348,269
| +23% | +$29.5M | 0.09% | 73 |
|
2022
Q2 | $126M | Buy |
1,526,003
+224,011
| +17% | +$18.6M | 0.08% | 100 |
|
2022
Q1 | $100M | Buy |
1,301,992
+593,956
| +84% | +$45.8M | 0.05% | 172 |
|
2021
Q4 | $62.6M | Sell |
708,036
-140,452
| -17% | -$12.4M | 0.03% | 332 |
|
2021
Q3 | $65.6M | Buy |
848,488
+807,552
| +1,973% | +$62.4M | 0.04% | 263 |
|
2021
Q2 | $3.42M | Sell |
40,936
-204,255
| -83% | -$17M | ﹤0.01% | 2573 |
|
2021
Q1 | $18.5M | Sell |
245,191
-226,302
| -48% | -$17.1M | 0.01% | 853 |
|
2020
Q4 | $41.3M | Sell |
471,493
-37,571
| -7% | -$3.29M | 0.03% | 380 |
|
2020
Q3 | $38.7K | Buy |
509,064
+374,732
| +279% | +$28.5K | 0.05% | 281 |
|
2020
Q2 | $16.6M | Sell |
134,332
-94,130
| -41% | -$11.6M | 0.02% | 649 |
|
2020
Q1 | $19.3M | Sell |
228,462
-381,353
| -63% | -$32.2M | 0.04% | 317 |
|
2019
Q4 | $51.6M | Buy |
609,815
+357,766
| +142% | +$30.2M | 0.06% | 256 |
|
2019
Q3 | $17M | Sell |
252,049
-159,380
| -39% | -$10.7M | 0.03% | 710 |
|
2019
Q2 | $35.2M | Buy |
411,429
+236,551
| +135% | +$20.3M | 0.05% | 406 |
|
2019
Q1 | $15.5M | Buy |
174,878
+68,586
| +65% | +$6.09M | 0.02% | 832 |
|
2018
Q4 | $9.05M | Sell |
106,292
-228,550
| -68% | -$19.5M | 0.01% | 1080 |
|
2018
Q3 | $32.5M | Sell |
334,842
-254,808
| -43% | -$24.7M | 0.04% | 557 |
|
2018
Q2 | $55.5M | Sell |
589,650
-55,750
| -9% | -$5.25M | 0.07% | 345 |
|
2018
Q1 | $52.3M | Buy |
645,400
+10,536
| +2% | +$854K | 0.07% | 390 |
|
2017
Q4 | $56.6M | Buy |
634,864
+160,132
| +34% | +$14.3M | 0.08% | 346 |
|
2017
Q3 | $44.2M | Sell |
474,732
-410,262
| -46% | -$38.2M | 0.07% | 380 |
|
2017
Q2 | $80.4M | Buy |
884,994
+882,017
| +29,628% | +$80.1M | 0.14% | 155 |
|
2017
Q1 | $261K | Buy |
+2,977
| New | +$261K | ﹤0.01% | 2870 |
|
2016
Q4 | – | Sell |
-337,301
| Closed | -$31.2M | – | 3116 |
|
2016
Q3 | $31.2M | Buy |
337,301
+275,632
| +447% | +$25.5M | 0.05% | 390 |
|
2016
Q2 | $4.8M | Sell |
61,669
-111,037
| -64% | -$8.64M | 0.01% | 1179 |
|
2016
Q1 | $14.2M | Sell |
172,706
-777,441
| -82% | -$64.1M | 0.04% | 612 |
|
2015
Q4 | $99.5M | Buy |
950,147
+218,723
| +30% | +$22.9M | 0.21% | 73 |
|
2015
Q3 | $77M | Sell |
731,424
-304,218
| -29% | -$32M | 0.15% | 135 |
|
2015
Q2 | $142M | Sell |
1,035,642
-158,000
| -13% | -$21.6M | 0.27% | 52 |
|
2015
Q1 | $149M | Buy |
1,193,642
+277,210
| +30% | +$34.5M | 0.28% | 49 |
|
2014
Q4 | $82.8M | Buy |
916,432
+229,533
| +33% | +$20.7M | 0.18% | 98 |
|
2014
Q3 | $49.6M | Sell |
686,899
-702,133
| -51% | -$50.7M | 0.13% | 154 |
|
2014
Q2 | $86.4M | Buy |
1,389,032
+1,356,725
| +4,199% | +$84.4M | 0.24% | 62 |
|
2014
Q1 | $2.2M | Sell |
32,307
-916,023
| -97% | -$62.5M | 0.01% | 1403 |
|
2013
Q4 | $66.7M | Buy |
948,330
+893,522
| +1,630% | +$62.9M | 0.21% | 66 |
|
2013
Q3 | $3.96M | Sell |
54,808
-183,357
| -77% | -$13.2M | 0.01% | 1011 |
|
2013
Q2 | $13.3M | Buy |
+238,165
| New | +$13.3M | 0.04% | 440 |
|